(Q48324194)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26559456%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

editorial

0 references

title

Vaccines for tick-borne diseases and cost-effectiveness of vaccination: a public health challenge to reduce the diseases' burden (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26559456%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26559456%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2

Maarten J Postma

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26559456%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

11 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26559456%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26559456%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26559456%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26559456%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

5-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26559456%20AND%20SRC:MED&resulttype=core&format=json

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1111142

Lyme borreliosis vaccination: the facts, the challenge, the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1111142

Tick borne encephalitis (TBE)-vaccination coverage and analysis of variables associated with vaccination, Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1111142

Review of tick-borne encephalitis and vaccines: clinical and economical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1111142

TBE--awareness and protection: the impact of epidemiology, changing lifestyle, and environmental factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1111142

TBE vaccination and the Austrian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1111142

The cost effectiveness of vaccinating against Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1111142

The cost-effectiveness of vaccination against Lyme disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1111142

Cost-effectiveness analysis of the Lyme disease vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1111142

Lyme borreliosis: reviewing potential vaccines, clinical aspects and health economics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1111142